Profile | Beth Mosher


Beth Mosher

 

Bio

 

Leveraging her background in anthropology, archaeology and industrial design, Beth Mosher uses human-centered research to power the design of both products and systems. She has worked as a senior designer at frog design for clients including Swatch, Next and IBM. She was also a member of Nike’s Advanced Product Engineering group, researching new material applications, the biomechanics of athletic endeavor and the cultural aspects of footwear and sports. Beth now works for clients on a broad range of projects from footwear to surgical devices.

 

Mosher is Associate Professor of Industrial Design at RISD and her teaching interests include design research, system design, future strategy and innovation. Her classes have included new ways to repurpose medical waste for Kimberly Clark and new systems to limit the human spread of invasive insects, in conjunction with the Harvard Arnold Arboretum.

 

She has presented ways to use design to increase community awareness and involvement in environmental remediation efforts to the Environmental Justice League of Rhode Island. And her current work probes the cues in junk food design that encourage over-consumption, to explore ways to reverse the trend. Her work has been exhibited both nationally and internationally and has been featured in Adbusters, Azure, Ottagono, Core 77 and Wired Magazine.

 


 

Work

 

Boston Scientific

SpyGlass Direct Visualization System

Redesigned physical interface of minimally-invasive surgical device to allow for gastrointestinal procedures to be performed by a single surgeon, allowing for a more widely available procedure. Involved in surgeon focus groups, motion analysis, ergonomic testing and wet labs. [Read More]

 

Medispectra

Designed physical interface of prototype laser scanner for cervical cancer. After conducted design research with doctors and patients, reconfigured internal components to make device more accurate and redesigned housing to make device less threatening, encouraging higher patient participation on FDA trials. [Read More]

 

 


 

Contact Beth Mosher